⌘K
t
Cambridge Cognition Holdings Plc announced on 18 October 2024 that it had received the formal resignation of Dr Matthew Stork as a Director of the Company and all subsidiary entities. This follows the 12 September 2024 announcement stating that Dr Stork had stepped down as Chief Executive Officer.
| Date | 18 Oct 2024 |
| Time | 07:00:05 |
| Category | Board changes |
| ID | 6785I |
18 October 2024
Cambridge Cognition Holdings plc
("Cambridge Cognition", the "Company" or the "Group")
Directorate change
Cambridge Cognition Holdings Plc (AIM: COG), which develops and markets digital solutions to assess brain health, announces that, further to the announcement made on 12 September 2024 in which it stated that Dr Matthew Stork had stepped down as Chief Executive Officer, the Company has now received the formal resignation of Dr Stork as a Director of the Company and all subsidiary entities of which he was a Director.
Enquiries:
|
|
Notes to Editors
About Cambridge Cognition
Cambridge Cognition is a technology company developing digital health products to better understand, detect and treat conditions affecting brain health. The Company's software products assess cognitive health in patients worldwide to improve clinical trial outcomes, identify and stratify patients early and improve global efficiency in pharmaceutical and healthcare industries.
For further information visit: https://cambridgecognition.com/